Cargando...
Inhibition of Epstein-Barr virus reactivation by the flavonoid apigenin
BACKGROUND: Lytic reactivation of EBV has been reported to play an important role in human diseases, including NPC carcinogenesis. Inhibition of EBV reactivation is considered to be of great benefit in the treatment of virus-associated diseases. For this purpose, we screened for inhibitory compounds...
Gardado en:
| Publicado en: | J Biomed Sci |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5217310/ https://ncbi.nlm.nih.gov/pubmed/28056971 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12929-016-0313-9 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|